Instil Bio TIL
NASDAQ TIL
$5.78 -0.16 (-2.61%)
As of: Oct 21, 2026 · 3:59 PM EDT

Instil Bio (TIL) Receivables - Other (2020 - 2021)

Updated

Instil Bio (TIL) reported Receivables - Other of $861,000 for Q3 2021, down 2.9% from the prior quarter.

Analysis

Instil Bio (TIL) Receivables - Other (2020 - 2021) Analysis & Trends

At the end of FY2020, Instil Bio posted Receivables - Other of $1.8 million.

  • Per Business Quant data, the three quarters before Q3 2021 came in at $887,000 (Q2 2021), $1.09 million (Q1 2021) and $1.8 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Instil Bio 38.86 Mn 15.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 861,000.00
Jun 30, 2021 887,000.00
Mar 31, 2021 1.09 Mn
Dec 31, 2020 1.80 Mn
API Access

Instil Bio Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TIL&period=max&api_key=YOUR_API_KEY